Literature DB >> 16792744

The Scotopic Sensitivity Tester-1 and the detection of early age-related macular degeneration.

Gregory R Jackson1, Tiffany Felix, Cynthia Owsley.   

Abstract

PURPOSE: Previous research shows that dark adaptation is a marker of early age-related macular degeneration (ARMD), even when visual acuity remains good. This study evaluates whether a commercially available, off-the-shelf device for measuring dark adaptation, the Scotopic Sensitivity Tester-1 (SST-1), which uses a full-field stimulus, detects early ARMD as defined by fundus appearance. Fundus appearance is the gold standard method for defining the presence of ARMD.
METHODS: Dark adaptation was measured using the SST-1 in 12 young adults (mean age 23 years), 17 old adults with normal retinal health (mean age 69) and 19 old adults with early ARMD (mean age 74). Normal retinal health and presence of early ARMD were defined by masked grading of dilated fundus photographs using the Wisconsin Age-Related Maculopathy Grading System.
RESULTS: Older adults in normal retinal health exhibited slower dark adaptation as compared with young adults. No difference in the rate of dark adaptation was found between early ARMD patients and older adults in normal retinal health.
CONCLUSIONS: Although the SST-1 differentiated between young and older adults, it failed to detect dark adaptation abnormalities in early ARMD when referenced against older adults in normal retinal health. This may be attributable to the full-field stimulation used by the SST-1, which may be better suited for characterizing retinal degenerations affecting large retinal areas than for focal macular diseases like ARMD.

Entities:  

Mesh:

Year:  2006        PMID: 16792744     DOI: 10.1111/j.1475-1313.2006.00390.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  9 in total

1.  Measurement of cone dark adaptation: a comparison of four psychophysical methods.

Authors:  Allannah J Gaffney; Alison M Binns; Tom H Margrain
Journal:  Doc Ophthalmol       Date:  2013-11-22       Impact factor: 2.379

2.  The repeatability of the Goldmann-Weekers adaptometer for measuring cone adaptation.

Authors:  Allannah J Gaffney; Alison M Binns; Tom H Margrain
Journal:  Doc Ophthalmol       Date:  2011-01-29       Impact factor: 2.379

3.  Retinal Structure in Pre-Clinical Age-Related Macular Degeneration.

Authors:  S Nusinowitz; Y Wang; P Kim; S Habib; R Baron; Y Conley; M Gorin
Journal:  Curr Eye Res       Date:  2017-11-14       Impact factor: 2.424

4.  Efficient assessment of the time course of perceptual sensitivity change.

Authors:  Yukai Zhao; Luis Lesmes; Zhong-Lin Lu
Journal:  Vision Res       Date:  2018-11-12       Impact factor: 1.886

5.  Portable Diagnostic System for Age-Related Macular Degeneration Screening Using Visual Evoked Potentials.

Authors:  Craig Versek; S Mohammad Ali Banijamali; Peter Bex; Kameran Lashkari; Sagar Kamarthi; Srinivas Sridhar
Journal:  Eye Brain       Date:  2021-04-29

6.  Endophenotypes for Age-Related Macular Degeneration: Extending Our Reach into the Preclinical Stages of Disease.

Authors:  Michael B Gorin; Daniel E Weeks; Robert V Baron; Yvette P Conley; Maria C Ortube; Steven Nusinowitz
Journal:  J Clin Med       Date:  2014-11-28       Impact factor: 4.241

Review 7.  Are Current Methods of Measuring Dark Adaptation Effective in Detecting the Onset and Progression of Age-Related Macular Degeneration? A Systematic Literature Review.

Authors:  Bethany E Higgins; Deanna J Taylor; Alison M Binns; David P Crabb
Journal:  Ophthalmol Ther       Date:  2021-02-09

8.  A short-duration dark adaptation protocol for assessment of age-related maculopathy.

Authors:  Gregory R Jackson; John G Edwards
Journal:  J Ocul Biol Dis Infor       Date:  2008-05-06

9.  Assessment of age changes and repeatability for computer-based rod dark adaptation.

Authors:  Laura Patryas; Neil R A Parry; David Carden; Daniel H Baker; Jeremiah M F Kelly; Tariq Aslam; Ian J Murray
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-05       Impact factor: 3.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.